Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/46185
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorPalenzuela, Oswaldo-
dc.contributor.authorSitjà-Bobadilla, Ariadna-
dc.contributor.authorRiaza, Ana-
dc.contributor.authorSilva, Raquel-
dc.contributor.authorArán, Javier-
dc.contributor.authorÁlvarez-Pellitero, Mª del Pilar-
dc.date.accessioned2012-02-24T10:21:13Z-
dc.date.available2012-02-24T10:21:13Z-
dc.date.issued2009-09-
dc.identifier.citationDiseases of aquatic organisms 86(2):123-134 (2009)es_ES
dc.identifier.issn0177-5103-
dc.identifier.urihttp://hdl.handle.net/10261/46185-
dc.description38 p., 7 figuras, 1 tabla y bibliografíaes_ES
dc.description.abstractThe kinetics of the antibody production and the protection at challenge were studied in turbot inoculated with various scuticociliate antigen preparations: live ciliates putatively attenuated through long-term in vitro culture (Trial 1) and formalin-killed ciliates without or with GERBU adjuvant in Trials 2, 3, and 4. Antigen used in killed preparations was a mixture of 3 different ciliate isolates (V3) in the case of Trials 2 and 3, whereas in Trial 4, monovalent (V1), trivalent (V3) or pentavalent (V5) antigens were used. A booster injection was administered 28 to 29 d post-priming in all trials. Fish were challenged with virulent live ciliates after the immunization protocol, testing 2 challenge times in Trial 2 (t1 and t2). No protection was obtained in Trial 1 with live ciliates, which in turn were not completely attenuated. Using killed-ciliate formulations, protection was high only in Trial 3 when a low dose (50 000 ciliates fish-1) was used for challenge. In Trial 1, heat-inactivated sera of antigen-inoculated fish agglutinated the homologous ciliate, although no specific antibodies were detectable by ELISA. In contrast, high specific antibody levels were detected in antigen-inoculated fish in Trials 2 and 4, and their amount increased progressively, usually peaking after challenge. No advantage was obtained from the use of V5 antigens compared to V1 or V3. No good correlation was observed in most cases between serum antibody levels and protection. Although the use of GERBU adjuvant generally increased the specific immune response, some undesired side effects indicate a need to adjust dosage and/or improve the formulation.es_ES
dc.description.sponsorshipThis study was partly funded by project PTR1995-0604-OP from the Spanish Ministerio de Ciencia y Tecnologíaes_ES
dc.language.isoenges_ES
dc.publisherInter Researches_ES
dc.rightsopenAccesses_ES
dc.subjectCiliateses_ES
dc.subjectScuticociliatiaes_ES
dc.subjectAdjuvantses_ES
dc.subjectAntibodieses_ES
dc.subjectImmunizationes_ES
dc.subjectFishes_ES
dc.subjectScophthalmus maximuses_ES
dc.titleAntibody responses of turbot Psetta maxima against various antigen formulations of scuticociliates Ciliophoraes_ES
dc.typeartículoes_ES
dc.identifier.doi10.3354/dao02102-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.3354/dao02102es_ES
dc.identifier.e-issn1616-1580-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextWith Fulltext-
item.openairetypeartículo-
Aparece en las colecciones: (IATS) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Antibody responses of turbot.pdf455,88 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

10
checked on 08-abr-2024

WEB OF SCIENCETM
Citations

9
checked on 28-feb-2024

Page view(s)

371
checked on 16-abr-2024

Download(s)

456
checked on 16-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.